These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 19307131)

  • 21. Guest editorial: concern over recent use of the ALARA philosophy.
    Auxier JA; Dickson HW
    Health Phys; 1983 Jun; 44(6):595-600. PubMed ID: 6853182
    [No Abstract]   [Full Text] [Related]  

  • 22. Ethyl methanesulfonate toxicity in Viracept--a comprehensive human risk assessment based on threshold data for genotoxicity.
    Müller L; Gocke E; Lavé T; Pfister T
    Toxicol Lett; 2009 Nov; 190(3):317-29. PubMed ID: 19443141
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low-dose extrapolation of radiation health risks: some implications of uncertainty for radiation protection at low doses.
    Land CE
    Health Phys; 2009 Nov; 97(5):407-15. PubMed ID: 19820450
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extended follow-up and spatial analysis of the American Cancer Society study linking particulate air pollution and mortality.
    Krewski D; Jerrett M; Burnett RT; Ma R; Hughes E; Shi Y; Turner MC; Pope CA; Thurston G; Calle EE; Thun MJ; Beckerman B; DeLuca P; Finkelstein N; Ito K; Moore DK; Newbold KB; Ramsay T; Ross Z; Shin H; Tempalski B
    Res Rep Health Eff Inst; 2009 May; (140):5-114; discussion 115-36. PubMed ID: 19627030
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low-dose cost/benefit assessment--a view from Europe.
    Becker K
    Health Phys; 1998 Feb; 74(2):267-71. PubMed ID: 9450599
    [No Abstract]   [Full Text] [Related]  

  • 26. Comment on "Low dose cost/benefit assessment--a view from Europe".
    Thomas RH
    Health Phys; 1998 Sep; 75(3):322-3. PubMed ID: 9721843
    [No Abstract]   [Full Text] [Related]  

  • 27. A critical evaluation of the cost-effectiveness of radon protection methods in new homes in a radon affected area of England.
    Coskeran T; Denman A; Phillips P; Tornberg R
    Environ Int; 2009 Aug; 35(6):943-51. PubMed ID: 19439356
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost-effectiveness analysis of micafungin versus fluconazole for prophylaxis of invasive fungal infections in patients undergoing hematopoietic stem cell transplantation in Korea.
    Sohn HS; Lee TJ; Kim J; Kim D
    Clin Ther; 2009 May; 31(5):1105-15; discussion 1066-8. PubMed ID: 19539111
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Implications for environmental health of multiple stressors.
    Mothersill C; Seymour C
    J Radiol Prot; 2009 Jun; 29(2A):A21-8. PubMed ID: 19454807
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost-benefit evaluation of a decentralized water system for wastewater reuse and environmental protection.
    Chen R; Wang XC
    Water Sci Technol; 2009; 59(8):1515-22. PubMed ID: 19403964
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Waste disposal and the recommendations of the International Commission on Radiological Protection - challenges for radioecology and environmental radiation protection.
    Larsson CM
    J Environ Radioact; 2009 Dec; 100(12):1053-7. PubMed ID: 19643515
    [TBL] [Abstract][Full Text] [Related]  

  • 32. On the need for a radon registry.
    Chen J
    J Radiol Prot; 2008 Mar; 28(1):117-8. PubMed ID: 18309201
    [No Abstract]   [Full Text] [Related]  

  • 33. Economic Considerations for Radiation Protection in Medical Settings-Is It Time for a New Paradigm?
    Demeter SJ
    Health Phys; 2021 Feb; 120(2):217-223. PubMed ID: 32740141
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A case study of cost-benefit analysis in occupational radiological protection within the healthcare system of Sweden.
    Engström A; Isaksson M; Javid R; Lundh C; Båth M
    J Appl Clin Med Phys; 2021 Oct; 22(10):295-304. PubMed ID: 34505345
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effectiveness of tritium beta particles.
    Bridges BA
    J Radiol Prot; 2008 Mar; 28(1):1-3. PubMed ID: 18309190
    [No Abstract]   [Full Text] [Related]  

  • 36. Radiation terrorism: what society needs from the radiobiology-radiation protection and radiation oncology communities.
    Coleman CN; Parker GW
    J Radiol Prot; 2009 Jun; 29(2A):A159-69. PubMed ID: 19454803
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optimization of radiation protection: a comparison of cost-benefit and risk-benefit analyses.
    Ancarani Rossiello L; Failla L
    Am Ind Hyg Assoc J; 1988 Jun; 49(6):A368-9. PubMed ID: 3135735
    [No Abstract]   [Full Text] [Related]  

  • 38. Towards a coherent conceptual framework for emergency preparedness/response and rehabilitation - the application of the new ICRP recommendations given in ICRP 103.
    Weiss W
    J Environ Radioact; 2009 Dec; 100(12):1002-4. PubMed ID: 19625114
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cancer and non-cancer effects in Japanese atomic bomb survivors.
    Little MP
    J Radiol Prot; 2009 Jun; 29(2A):A43-59. PubMed ID: 19454804
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comment on the invited editorial 'Effectiveness of tritium beta particles'.
    Müller WU
    J Radiol Prot; 2008 Jun; 28(2):249-52; author reply 250-1. PubMed ID: 18506081
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.